Plasma miR-151-3p as a Candidate Diagnostic Biomarker for Head and Neck Cancer: A Cross-sectional Study within the INHANCE Consortium.
Roberta PastorinoMichele SassanoDanilo Francesco TizianoLuca GiraldiRosarita AmoreDario ArzaniEmanuela AbiusiWolfgang AhrensLaia Alemany VilchesCristina CanovaClaire Mary HealyIvana HolcatovaPagona LagiouJerry PoleselMaja PopovićStåle NygardGabriella CadoniAriana ZnaorPaolo BoffettaKeitaro MatsuoIsao OzePaul J BrennanStefania BocciaPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2022)
The prognosis for HNC is still poor. The discovery of a new diagnostic biomarker could lead to an earlier tumor discovery and therefore to an improvement in patient prognosis.